E-CEL UVEC cells Therapy(Angiocrine Bioscience)

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameE-CEL UVEC cells Therapy(Angiocrine Bioscience)
Drug Alias NameE-CEL UVEC Cell TherapyE-CEL UVEC CellsE-CEL UVECAB-207
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPerianal fistulaRotator Cuff InjuriesMuscular Atrophy +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAngiocrine Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesWeill Medical College of Cornell UniversityAngiocrine Bioscience Inc
Inactive CompaniesN/A
Active IndicationsPerianal fistulaRotator Cuff InjuriesMuscular Atrophy +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A